TalkMed Group

'We have yet to deploy it at the clinics. We plan to apply for its use when we have eligible patients,' says TalkMed

The group has proposed a final dividend of 0.90 cents, which will be paid on May 11.

The JV is set up with Chongqing Yijiasheng Pharma Technology and Chongqing Tuozhen Information Technology

In 4QFY2019, revenue for the group increased 16.6% to $22.10 million on the back of an increase in the number of patient visits. But rising competition and the COVID-19 outbreak is expected to present some challenges this year.

SINGAPORE (Feb 19): TalkMed Group posted a 16.4% increase in earnings to $9.6 million for the 4Q18 ended December, from $8.2 million a year ago.

SINGAPORE (May 23): Stocks of the 15 largest Singapore-listed healthcare equipment and services companies with market caps above $100 million, have gained an average 9.2% year to date, according to data from the Singapore Exchange.

SINGAPORE (Apr 24): TalkMed Group, which provides private healthcare services in the fields of medical oncology through Parkway Cancer Centre in Singapore, reported a 37.2% fall in first quarter earnings to $5.06 million in 1Q18 from $8.39 million in 1Q17

SINGAPORE (Feb 20): TalkMed Group reported 4Q17 earnings fell 19.3% to $8.2 million from $10.2 million a year ago mainly due to a decrease in revenue.

SINGAPORE (Jan 8): Although healthcare stocks in Singapore underperformed last year largely due to the setting up of new hospitals overseas, CIMB says the sector would be rerated once they stabilised.

SINGAPORE (Jan 8): CIMB is maintaining its “hold” call on TalkMed Group with a lower target price of 68 cents from 92 cents previously, after cutting FY17-19F earnings per share (EPS) estimates by 18-21% to factor anticipated earnings losses from the